Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Why Trump’s opponents defend him

Published

on

In the latest round of indictments against former President Donald Trump, his Republican opponents had an opportunity to distance themselves from him.

However, instead of criticizing Trump’s alleged attempt to overturn the 2020 election, most of his rivals opted to criticize the Department of Justice, giving him a lifeline in the face of criminal charges related to the January 6 attack on the U.S. Capitol.

Trump’s rivals seem to be banking on the hope that something, such as legal proceedings or a health crisis, will weaken his candidacy, allowing them to appeal to his loyal base and win the nomination.

FILE: Trump supports riot outside the Capitol building.

Trump’s Teflon-like resilience in the face of indictments makes it challenging for his opponents to criticize him effectively. His strong base of supporters is a significant factor in the calculations of his primary opponents, as they need to win over these voters to have a chance at becoming the nominee.

Trump’s valuable base

Fear of alienating Trump’s base has led most of his opponents to avoid direct criticism, focusing instead on blaming the “D.C. swamp” or “Biden’s DOJ.”

Despite Trump’s legal troubles, a large portion of likely Republican primary voters still view him favorably, and they do not believe he committed serious federal crimes or threatened democracy.

Some candidates, like Florida Gov. Ron DeSantis and entrepreneur Vivek Ramaswamy, continue to portray Trump as a victim of the Justice Department, using that narrative to appeal to his base.

Former South Carolina Gov. Nikki Haley remained notably quiet and did not address the latest indictment, which makes it challenging for other candidates to differentiate themselves from Trump and gain ground in the race.

Trump’s allies continue to offer strong support, and his opponents struggle to catch up and peel away his loyal supporters. As his Washington, D.C. arraignment approaches, Trump acknowledges the unwavering support he receives.

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

on

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

News

Apple responds to crushing iPad Pro criticism

Published

on

Apple issued an apology following backlash over a recent advertisement for the latest iPad Pro.

On this episode of Ahron & Mike Live – Painted Panda dogs confuse zoo goers, luxury Police cars cruise the roads, Siri meets up with ChatGpt and Apple’s “Crush” iPad ad faces overwhelming backlash.

Ticker’s Ahron Young & Mike Loder discuss. #featured #trending

Continue Reading

Money

Why the meme-stock frenzy is unlikely to repeat

Published

on

GME shares surge 74%, but experts stress a meme-stock frenzy resurgence is unlikely due to fundamental differences in the company’s financial situation.

Australia’s budget unveils a second consecutive surplus of A$9.3 billion, prioritising the critical minerals industry and green energy initiatives to reduce reliance on Chinese supply.

Also, GameStop shares have surged 74%, but experts caution against expecting a repeat of the 2021 meme-stock frenzy. #featured #trending

Continue Reading

Trending Now